Skip to main content
OpenTrials
Completed

NCT Number: NCT06488690

Early Warning Scores in Pregnant Woman

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy Complications Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Suleyman Demirel University

Isparta, Merkez, 32200, Turkey (Türkiye)

About this study

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023. Physiological parameters were assessed in all 304 pregnant women before the operation. Maternal early warning scores, including modified early obstetric warning score (MEOWS), maternal early warning score (MEWC), and maternal early warning triggers (MEWT), were calculated for each patient. Patients triggering the system were classified as Group 1 (risky patients), while those not triggering the system were classified as Group 2 (risk-free patients).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients who are pregnant and undergo cesarean section

Exclusion criteria

  • None

Treatment and study plan

All patients who were pregnant and underwent cesarean section

Other

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Primary outcomes

  1. MEOWS, MEWC and MEWT scores

    Time frame: One year

    The presence of a "trigger" for MEOWS in all systems, defined as either a single severely abnormal parameter (falling in the "red" zone) or two slightly abnormal parameters (falling in the "yellow" zone), was categorized as the risky group. Absence or mildness of the trigger was considered as the risk-free group.

  2. MEWC score

    Time frame: One year

    In the case of MEWC, the presence of only one abnormal parameter designated the risk group, while the absence of a trigger indicated the risk-free group.

  3. MEWT score

    Time frame: One year

    For MEWT, the presence of a "trigger" defined as either a single severely abnormal parameter (falling in the "red" zone) or two mildly abnormal parameters (falling in the "yellow" zone) was categorized as the risky group, with the absence or mildness of the trigger considered as the risk-free group.

Secondary outcomes

  1. APGAR score

    Time frame: One year

    APGAR scores at 1st and 5th minutes were calculated for postnatal babies.

  2. Aldrete score

    Time frame: One year

    The Modified Aldrete Recovery Score System was computed for mothers to assess postoperative recovery.

  3. Glasgow Coma Scale

    Time frame: One year

    The Glasgow Coma Scale (GCS) was used to evaluate the consciousness of pregnant women.

Sponsors and collaborators

Lead sponsor

Suleyman Demirel University

Other

Registry information

Official study title

Effectiveness of Early Warning Scores: Preoperative Period in Pregnant Women

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Jul 5, 2024
Registry last updated
Jul 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.